Andere Sprachen BetterLife Pharma Inc.

Aktien

A2P7XN

CA08772P2026

BETRF

Markt geschlossen - OTC Markets Andere Börsenplätze 20:09:36 03.05.2024			% 5 Tage	% 1. Jan.
0,0952 ^USD	+9,47 %		+32,41 %	+98,33 %

01.05.	BetterLife Pharma treibt die IND-zulassenden Studien für BETR-001 voran	MT
01.05.	BetterLife Pharma Inc. macht Fortschritte bei den IND-Zulassungsstudien für BETR-001	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

BetterLife Pharma Advances IND-enabling Studies For BETR-001	01.05.
BetterLife Advances BETR-001 IND-enabling Studies	01.05.
BetterLife Advances BETR-001 IND-enabling Studies	01.05.
BetterLife Pharma Inc. Advances BETR-001 IND-Enabling Studies	01.05.
BetterLife Pharma Inc. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	15.04.
BetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	11.04.
BetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	11.04.
BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001	03.04.
BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001	03.04.
BetterLife Pharma Inc. announced that it has received CAD 1.168 million in funding	03.04.
BetterLife’s 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton University	04.03.
BetterLife’s 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton University	04.03.
BetterLife Pharma Inc. announced that it expects to receive CAD 0.1 million in funding	04.03.
BetterLife Pharma Inc. announced that it has received CAD 0.065 million in funding	04.03.
BetterLife Closes Convertible Debentures For Further Development of BETR-001	02.01.
BetterLife Announces Closing of Convertible Debentures For Further Development of BETR-001	02.01.
BetterLife Pharma Inc. announced that it has received CAD 0.3 million in funding	02.01.
BetterLife Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023	29.12.
BetterLife Pharma : MANAGEMENT'S DISCUSSION AND ANALYSIS - Form 6-K	29.12.
BetterLife Announces Closing of a Private Placement	18.12.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen BetterLife Pharma Inc.

Aktien

A2P7XN

CA08772P2026

BETRF

Andere Sprachen

Filter